
Keywords: لیپوپروتئین کم چگالی یا الدیال ; apoA-1; apolipoprotein A-1; apoB; apolipoprotein B-100; CEC; cholesterol efflux capacity; CVD; cardiovascular disease; HDL; high-density lipoprotein; HOMA-IR; homeostasis model assessment of insulin resistance; LDL; low-density lipoprotein;